Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
Fig 4
Cell cycle distribution in A549 and A549rCDDP2000 cells.
Cell fraction of the flow cytometric cell cycle analysis is presented in % of total cell population in a) G1/G0-phase, b) G2/M-phase and c) S-phase in A549 and A549rCDDP2000 cells as untreated controls or after treatment with 11 μM or 34 μM cisplatin presented as mean ± SEM.
doi: https://doi.org/10.1371/journal.pone.0181081.g004